FMR LLC - 31 Dec 2024 SCHEDULE 13G/A Report for VERTEX PHARMACEUTICALS INC COMMON STOCK (VRTX)

Filing Manager
FMR LLC
Reporting Manager
FMR LLC
Security
VERTEX PHARMACEUTICALS INC COMMON STOCK
Symbol
VRTX
Shares outstanding
256,134,077 shares
Disclosed Ownership
9,220,827 shares
Ownership
3.6%
Form type
SCHEDULE 13G/A
Filing time
12 Feb 2025, 09:34:21 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"FMR LLC disclosed 3.6% ownership in VERTEX PHARMACEUTICALS INC COMMON STOCK (VRTX) on 31 Dec 2024."

Quick Takeaways

  • FMR LLC filed SCHEDULE 13G/A for VERTEX PHARMACEUTICALS INC COMMON STOCK (VRTX).
  • Disclosed ownership: 3.6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 12 Feb 2025, 09:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
FMR LLC 3.6% 9,220,827 8,484,282 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Abigail P. Johnson 3.6% 9,220,827 0 0 Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**

Sponsored